Genmab Has First Wholly Owned Antibodies In Phase III, Hunts For More

Shifting From Out-Licensing To Retaining Assets

 
• By Mandy Jackson
  
Genmab bought ProfoundBio last year and hopes to sign another deal this year (Shutterstock)
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Growth

More from Leadership